Eugene

[email protected]

LATEST

Sandoz, Polpharma Biologics Partner for Biosimilar of Biogen’s MS Drug Tysabri
By

By
Sandoz, the generics arm of Novartis, has partnered with Polpharma Biologics, a European developer and manufacturer of biosimilars and biologic drugs, for global commercialization of a proposed biosimilar of Biogen’s…

Roche Extends Tender Offer in Pending $4.3-Billion Acquisition of Spark Therapeutics
By

By
Roche has extended its tender offer period relating to its pending $4.3-billion acquisition of Spark Therapeutics, a Philadelphia-based gene-therapy company, from September 3, 2019 to October 1, 2019. Roche had…

Schott and PCI Pharma Services Expand; Ajinomoto Bio-Pharma Services To Buy Out JV in India
By

By
The latest news from CDMOs, CMOs, and suppliers featuring news from Schott, PCI Pharma Services, Ajinomoto Bio-Pharma Services, LBB Specialties, and Meggle. Chemicals/Chemical API Manufacturing Ajinomoto Bio-Pharma Services To Buy…

EMA, FDA Analysis Shows High Degree of Alignment in Drug Approvals
By

By
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have published a joint analysis that shows the two are aligned in more than 90% of marketing…

Celgene, Immatics Form Collaboration for Adoptive Cell Therapies
By

By
Celgene and Immatics Biotechnologies, a clinical-stage pharmaceutical company developing T-cell redirecting cancer immunotherapies, have formed a strategic collaboration and option agreement to develop adoptive cell therapies targeting multiple cancers. Under…

Global Pharma Briefs: News from Europe, Asia and the Middle East
By

By
A roundup of developments and latest news from China (iBio, CC-Pharma), Japan (Neopharma, Lupin) and United States (Glenmark, Strides Pharma). China iBio and CC-Pharming Expand Business Collaboration in China iBio,…

SWK Acquires Oral Drug-Delivery Specialist Enteris BioPharma for $21.5 Million
By

By
SWK Holdings Corporation, a life-science specialty finance company, has acquired Enteris BioPharma, a company specializing in oral peptide drug-delivery technology, for $21.5 million. SWK acquired Enteris BioPharma from Victory Park…

BI Appoints New Head of Pharmaceuticals Business
By

By
Boehringer Ingelheim (BI) reports that Allan Hillgrove, member of the company’s Board of Managing Directors responsible for the Human Pharma and the Biopharma business, will retire at the end of…

FDA Updates Plan for Evaluating Mfg Issues in Sartan Products
By

By
The US Food and Drug Administration (FDA) has provided an update to the agency’s ongoing investigation surrounding voluntary recalls of multiple generic “sartan”-containing products, angiotensin II receptor blockers (ARBs), used…

J&J To Appeal Oklahoma’s $572-Million Civil Judgement in Opioid Case
By

By
Johnson & Johnson (J&J) and its Janssen Pharmaceutical Companies say they will appeal a $572-million civil judgement entered in Cleveland County District Court in the State of Oklahoma’s lawsuit against…